Effect of botulinum toxin on hamstring contracture and the occurrence of cyclops syndrome following anterior cruciate ligament reconstructio
Phase 1
Recruiting
- Conditions
- Cyclops syndromeMedDRA version: 20.0Level: PTClassification code: 10058029Term: Arthrofibrosis Class: 100000004859Therapeutic area: Analytical,Diagnostic,Therapeutic Techniques and Equipment [E]-Surgical Procedures, Operative [E04]
- Registration Number
- CTIS2023-509193-32-01
- Lead Sponsor
- Ramsay Generale De Sante
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 132
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie botulinum toxin's effect on hamstring contracture and cyclops syndrome post-ACL reconstruction?
How does botulinum toxin compare to corticosteroid injections in preventing cyclops syndrome after ACL surgery?
Are there specific biomarkers that predict response to botulinum toxin in post-ACL arthrofibrosis management?
What are the potential adverse events associated with botulinum toxin administration in orthopedic surgical recovery?
What combination therapies with botulinum toxin show promise in treating post-surgical joint stiffness and fibrosis?